Related Experiment Videos
Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study
I W Iglehart1, J D Sutton, J C Bender
1Division of Rheumatology, The Johns Hopkins Medical Institutions, Good Samaritan Hospital, Baltimore, MD.
The Journal of Rheumatology
|February 1, 1990
Summary
Low-dose intravenous methylprednisolone (MP) minipulse therapy is as effective as standard pulse therapy for treating rheumatoid arthritis (RA) flares. This finding offers a potentially less intensive treatment option for RA patients experiencing synovitis flares.
Area of Science:
- Rheumatology
- Clinical Pharmacology
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitis.
- Intravenous methylprednisolone (MP) pulse therapy is a common treatment for RA flares.
- Standard pulse therapy involves high doses (1000 mg) of MP.
Purpose of the Study:
- To compare the efficacy of intravenous "minipulse" (100 mg) methylprednisolone (MP) therapy versus standard pulse (1000 mg) MP therapy in patients with rheumatoid arthritis (RA).
Main Methods:
- Prospective, double-blind, randomized study.
- Thirty-six patients with RA synovitis flares were enrolled.
- Participants received either 100 mg or 1000 mg of MP intravenously once daily for three doses.
Main Results:
- No statistically significant differences were observed between the two groups in terms of prompt and sustained clinical improvement.
- Both minipulse (100 mg) and standard pulse (1000 mg) MP therapies demonstrated comparable efficacy in treating RA flares.
Conclusions:
- Minipulse intravenous MP therapy is as efficacious as conventional pulse MP therapy for managing rheumatoid arthritis flares.
- Lower dose MP therapy may represent a viable alternative for RA treatment, potentially reducing side effects associated with higher doses.